OPALO Gold Concession in Chile, with Inferred Gold Resources of Close to 7 Million Ounces, Acquired by Russian Group
OPALO, a fully registered gold concession in Chile, comprising a property with inferred gold resources of close to 7 million ounces, was recently acquired by a Russian management group led by Rauf Kasumov. The OPALO transaction was executed at the Chilean consulate in Moscow.
In the last decades, Chile has been a preferred destination for international mining companies such as BHP Billiton, Anglo American, Freeport McMoran and Barrick Gold.
Among Mr. Kasumov’s successful professional endeavours is his key role participation in the construction of Akkuyu Nuclear Plant in Turkey, the largest investment to date in the country.
UFP Capital SA (“UFP”), a subsidiary of United First Partners, a global special situations group, is acting as the exclusive advisor of Mr. Kasumov. UFP will entertain discussions with relevant industrial and financial partners in the near term to prepare a coherent value creation plan for OPALO.
For more information contact Opalo@ufp-capital.com
Name of Contact: Stephane Mardel
Company Name: UFP Capital SA – Switzerland
Information om Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco
Følg pressemeddelelser fra Business Wire
Skriv dig op her og modtag pressemeddelelser på mail. Indtast din mail, klik på abonner og følg instruktionerne i den udsendte mail.
Flere pressemeddelelser fra Business Wire
TX-SCHLUMBERGER16.11.2018 19:02 | pressemeddelelse
Schlumberger Announces Fourth-Quarter and Full-Year 2018 Results Conference Call
CA-VISA16.11.2018 15:35 | pressemeddelelse
Visa Strengthens Commitment to Growing Digital Payments in India
CA-ANDERSEN-TAX16.11.2018 15:04 | pressemeddelelse
Andersen Global Tilføjer Tax & Legal Services i Argentina
CA-GUIDEWIRE-SOFTWARE16.11.2018 14:57 | pressemeddelelse
Guidewire Enhances PartnerConnect Consulting Program with Addition of Product and Regional Specializations
JANSSEN16.11.2018 14:17 | pressemeddelelse
Janssen receives positive CHMP opinion for ERLEADA™ (apalutamide) for patients with non-metastatic castration-resistant prostate cancer who are at high risk of developing metastatic disease
VERTEX-PHARMA16.11.2018 13:59 | pressemeddelelse
Vertex Receives European CHMP Positive Opinion for ORKAMBI® (lumacaftor/ivacaftor) for Treatment of Children with Cystic Fibrosis Aged 2 to 5 Years Old with Most Common Form of the Disease
I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter, og finde vores kontaktoplysninger.Besøg vores nyhedsrum